Home · Compare

Mayukh Sukhatme vs N.M. Westfall

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $246.7M (4800%) more than N.M. Westfall in their most recent fiscal years on record.

Mayukh SukhatmeN.M. Westfall

CompanyRoivant SciencesChemed Corporation

TitlePresident and Chief Investment OfficerExecutive Officer

IndustryHealthcareHealthcare

Fiscal YearFY2024FY2024

Total Pay$251.9M$5.1M

Base Salary$550,000$667,125

Stock Awards$170.2M$2.6M

Bonus$81.1M—

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Mayukh Sukhatme's full profile · N.M. Westfall's full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy